Clinical experience with α-galactosylceramide (KRN7000) in patients with advanced cancer and chronic hepatitis B/C infection.

F.L. Schneiders; R.J. Scheper; B.M.E. von Blomberg; A.M. Woltman; H.L.A. Janssen; A.J.M. van den Eertwegh; H.M.W. Verheul; T.D. de Gruijl; J.J. van der Vliet

doi:10.1016/j.clim.2010.11.010

Clinical experience with α-galactosylceramide (KRN7000) in patients with advanced cancer and chronic hepatitis B/C infection.

F.L. Schneiders, R.J. Scheper, B.M.E. von Blomberg, A.M. Woltman, H.L.A. Janssen, A.J.M. van den Eertwegh, H.M.W. Verheul, T.D. de Gruijl, J.J. van der Vliet

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	130-141
Journal	Clinical Immunology
Volume	140
Issue number	2
DOIs	https://doi.org/10.1016/j.clim.2010.11.010
Publication status	Published - 2011

Access to Document

10.1016/j.clim.2010.11.010

Cite this

Schneiders, F. L., Scheper, R. J., von Blomberg, B. M. E., Woltman, A. M., Janssen, H. L. A., van den Eertwegh, A. J. M., Verheul, H. M. W., de Gruijl, T. D., & van der Vliet, J. J. (2011). Clinical experience with α-galactosylceramide (KRN7000) in patients with advanced cancer and chronic hepatitis B/C infection. Clinical Immunology, 140(2), 130-141. https://doi.org/10.1016/j.clim.2010.11.010

@article{523b9414925d4c6e84ac74620419daf6,

title = "Clinical experience with α-galactosylceramide (KRN7000) in patients with advanced cancer and chronic hepatitis B/C infection.",

author = "F.L. Schneiders and R.J. Scheper and {von Blomberg}, B.M.E. and A.M. Woltman and H.L.A. Janssen and {van den Eertwegh}, A.J.M. and H.M.W. Verheul and {de Gruijl}, T.D. and {van der Vliet}, J.J.",

year = "2011",

doi = "10.1016/j.clim.2010.11.010",

language = "English",

volume = "140",

pages = "130--141",

journal = "Clinical Immunology",

issn = "1521-6616",

publisher = "Academic Press Inc.",

number = "2",

}

Schneiders, FL , Scheper, RJ, von Blomberg, BME, Woltman, AM, Janssen, HLA, van den Eertwegh, AJM, Verheul, HMW, de Gruijl, TD & van der Vliet, JJ 2011, 'Clinical experience with α-galactosylceramide (KRN7000) in patients with advanced cancer and chronic hepatitis B/C infection.', Clinical Immunology, vol. 140, no. 2, pp. 130-141. https://doi.org/10.1016/j.clim.2010.11.010

TY - JOUR

T1 - Clinical experience with α-galactosylceramide (KRN7000) in patients with advanced cancer and chronic hepatitis B/C infection.

AU - Schneiders, F.L.

AU - Scheper, R.J.

AU - von Blomberg, B.M.E.

AU - Woltman, A.M.

AU - Janssen, H.L.A.

AU - van den Eertwegh, A.J.M.

AU - Verheul, H.M.W.

AU - de Gruijl, T.D.

AU - van der Vliet, J.J.

PY - 2011

Y1 - 2011

U2 - 10.1016/j.clim.2010.11.010

DO - 10.1016/j.clim.2010.11.010

M3 - Article

C2 - 21169066

VL - 140

SP - 130

EP - 141

JO - Clinical Immunology

JF - Clinical Immunology

SN - 1521-6616

IS - 2

ER -